|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 706 JPY | -0.56% |
|
+2.92% | +24.51% |
Oncolys BioPharma Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was JPY 35 million compared to JPY 193.13 million a year ago. Net loss was JPY 323.69 million compared to JPY 328.96 million a year ago.
Basic loss per share from continuing operations was JPY 18.69 compared to JPY 18.98 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +24.51% | 95.81M | |
| -3.79% | 87.06B | |
| +1.45% | 40.25B | |
| -15.94% | 31.09B | |
| +52.66% | 24.74B | |
| -14.50% | 15.91B | |
| -9.12% | 11.96B | |
| -14.38% | 11.92B | |
| -42.56% | 11.61B | |
| +4.87% | 8.73B |
ONCOLYS BIOPHARMA INC. 
